On the other hand, investigating those NSCLC neither having distinct adenoid or squamous morphological features nor expressing TTF1 or p63, thus being classified as NSCLC NOS, expression of neuroendocrine markers indeed revealed a distinct separation of the obtained survival curves with a statistical trend (p = 0.095; figure S5). The gene discussed is TTF1; the disease is non-small cell lung carcinoma.